These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 17549577)
21. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. L'Hermite M Climacteric; 2017 Jun; 20(3):205-211. PubMed ID: 28509626 [TBL] [Abstract][Full Text] [Related]
22. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329 [TBL] [Abstract][Full Text] [Related]
23. Bioidentical hormones: what is all the hype about? Panay N; Fenton A Climacteric; 2010 Feb; 13(1):1-3. PubMed ID: 20067429 [No Abstract] [Full Text] [Related]
25. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review. Files J; Kling JM Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776 [No Abstract] [Full Text] [Related]
26. Guidelines for hormone treatment of women in the menopausal transition and beyond. Naftolin F; Schneider HP; Sturdee DW; Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104 [No Abstract] [Full Text] [Related]
27. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs. Patsner B Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473 [No Abstract] [Full Text] [Related]
28. Bioidentical hormones: panacea for menopausal hormonal therapy or bio-beware? Hansen K S D Med; 2008 Jul; 61(7):244-5. PubMed ID: 18717291 [No Abstract] [Full Text] [Related]
29. Bioidentical hormones. The bottom line on compounded hormones. Mayo Clin Womens Healthsource; 2005 Sep; 9(9):1-2. PubMed ID: 16142198 [No Abstract] [Full Text] [Related]
30. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
31. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR Menopause; 2008; 15(1):94-7. PubMed ID: 17882008 [TBL] [Abstract][Full Text] [Related]
32. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
33. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Pinkerton JV; Santoro N Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877 [TBL] [Abstract][Full Text] [Related]
34. Evidence on the use of progesterone in menopausal hormone therapy. Mirkin S Climacteric; 2018 Aug; 21(4):346-354. PubMed ID: 29630427 [TBL] [Abstract][Full Text] [Related]
36. Compounded bioidentical hormone therapy: new recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine. Stuenkel CA Menopause; 2021 Mar; 28(5):576-578. PubMed ID: 33739316 [TBL] [Abstract][Full Text] [Related]
37. Benefits and risks of long-term low-dose oral continuous combined hormone therapy. van de Weijer PH; Mattsson LA; Ylikorkala O Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966 [TBL] [Abstract][Full Text] [Related]
38. Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies. Stanczyk FZ; Niu C; Azen C; Mirkin S; Amadio JM Menopause; 2019 Sep; 26(9):966-971. PubMed ID: 31453957 [TBL] [Abstract][Full Text] [Related]
39. Clinical practice. Management of menopausal symptoms. Grady D N Engl J Med; 2006 Nov; 355(22):2338-47. PubMed ID: 17135587 [No Abstract] [Full Text] [Related]